Farms.com Home   News

Concrete Flowing Into CWB's New Elevator At Bloom, MB

Concrete has started to flow into CWB's new grain elevator located west of Portage la Prairie in Bloom, Manitoba.

Pouring of the concrete slip began on Monday, September 15 and is expected to be completed Saturday.

The 65-member crew is pouring one foot of concrete per hour and once complete the 130 foot tall structure will contain more than 2100 cubic meters of concrete and 250,000 kilograms of steel.

"There is a flurry of 24-7 activity with trucks arriving every 40 minutes carrying the concrete required to complete the pour," said Gord Flaten, Vice-President, Grain Procurement. "Once the slip pour is complete, the interior work will get underway throughout the fall and winter with the installation of equipment and control systems. Next summer the storage bins will be filled with grain to settle the foundation."

CWB's Bloom elevator is expected to start receiving grain for the 2015 harvest.

Source: PortageOnline


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.